Contents
- 1 Table of Contents
- 2 TBO Tek IPO Vs Indegene Limited IPO
- 3 TBO Tek IPO Vs Indegene Limited IPO Dates
- 4 TBO Tek IPO Vs Indegene Limited IPO Lot Size
- 5 TBO Tek IPO Vs Indegene Limited GMP (Gray Market Premium) Comparison
- 6 TBO Tek IPO Vs Indegene Limited Company Details
- 7 An object of the Issue TBO Tek IPO Vs Indegene Limited IPO
- 8 TBO Tek Limited Vs Indegene Limited Financial Status (Restated)
TBO Tek IPO Vs Indegene Limited IPO: Two Mainboard IPOs open for subscription this May 2024. TBO Tek IPO going to open on the date May 08, 2024, and Indegene Limited IPO will be open for subscription on May 06, 2024.
For this reason, TBO Tek IPO Vs Indegene Limited IPO compression is most important for investors to analyse both Mainboard IPOs.
Table of Contents
TBO Tek IPO Vs Indegene Limited IPO
| Components | TBO Tek IPO | Indegene Limited IPO |
| Open Date | 08th May 2024 | 06th May 2024 |
| Close Date | 08 May 2024 | 10 May 2024 |
| Listing Date | 13th May 2024 [Expected] | 15th May 2024 [Expected] |
| IPO Size | Aggregating ₹[.] Lakhs through [.] lakh shares | Aggregating ₹1,84176 Lakhs through 40,746,891 lakh shares |
| Face Value | ₹1 per share | ₹2 per share |
| IPO Price Band | ₹[.] to ₹[.] per share | ₹430 to ₹452 per share |
| IPO Listing on | BSE SME | BSE SME |
| Lot Size | [.] Shares | 33 Shares |
| OFS | 1.25 crore shares with a face value of ₹1 | 23,932,732 shares aggregating up to ₹1,08176 Lakh |
| Retail Quota | 10%of the total issue share | 35%of the total issue share |
| QBI | 75% of the total issue share | 50% of the total issue share |
| HNI | 15% of the total issue share | 15% of the total issue share |
*Details Comparison
TBO Tek IPO Vs Indegene Limited IPO Dates
| Event | TBO Tek IPO | Indegene Limited IPO |
|---|---|---|
| IPO Open Date | May 8, 2024 | 6th May 2024 |
| IPO Close Date | May 10, 2024 | 8th May 2024 |
| Basis of Allotment | May 13, 2024 | 9th May 2024 |
| Initiation of Refunds | May 14, 2024 | 10th May 2024 |
| Credit of Shares | May 14, 2024 | 10th May 2024 |
| Listing Date | May 15, 2024 | 13th May 2024 |
| UPI Mandate Confirm | 5 PM on May 10, 2024 | 5 PM on 8th May 2024 |
TBO Tek IPO Vs Indegene Limited IPO Lot Size
| Applicants | TBO Tek IPO Lot Size (Min & Max) | Share | Amount | Indegene Ltd IPO Lot Size (Min & Max) | Share | Amount |
|---|---|---|---|---|---|---|
| Retail | 1 Lot (Min) [. lot (Max)] | [.] | [.] Max | 1 Lot (Min) 13 Lots Max | 33 | ₹14916 – ₹193,908 Max |
| S-HNI | [.] Lot Min. | [.] | ₹[.] Min | 14 Lots Min. | 462 | ₹208,824 Min |
| B-HNI | [.] Lot Min. | [.] | [.] Min | 14 Lots Min. | 462 | ₹208,824 Min |
TBO Tek IPO Vs Indegene Limited GMP (Gray Market Premium) Comparison
| Date | TBO Tek IPO GMP | IPO Price | Estimate Listing Price | Update On | Indegene Limited IPO GMP | IPO Price | Estimate Listing Price | Update On |
|---|---|---|---|---|---|---|---|---|
| 30/04/2024 | ₹0 | ₹[.] | ₹[.] | 30/04/2024 19:00 | ₹205 | ₹452 | ₹657 | 30/04/2024 17:27 |
| 29/04/2024 | ₹0 | ₹[.] | ₹[.] | 29/04/2024 15:00 | ₹169 | ₹452 | ₹621 | 29/04/2024 15:19 |
For Live IPO Subscription Status Visit – Live IPO Subscription Status
TBO Tek IPO Vs Indegene Limited Company Details
| Aspect | TBO Tek Limited | Indegene Limited |
|---|---|---|
| Establishment Year | 2006 | Not specified |
| Previous Name | Tek Travels Private Limited | Indegene Limited |
| Industry Focus | Travel Distribution Platform | Life Sciences Solutions |
| Services | Travel distribution platform – Forex assistance | Commercial operations – Medical affairs – Regulatory compliance – Research and development Product lifecycle solutions |
| Clients | Hotels – Airlines – Car rentals – Transfers – Cruises – Insurance providers – Rail companies | Biopharmaceutical companies – Emerging biotech companies – Medical device companies |
| Customer Base | Travel agencies – Independent travel consultants – Tour operators – Travel management companies | Life sciences companies |
| Technology Platform | A bridge between suppliers and customers – Multi-currency and multi-lingual platform – Seamless connections | Not specified |
| Coverage | Over 7,500 destinations – 100+ countries | Global market |
An object of the Issue TBO Tek IPO Vs Indegene Limited IPO
| Objectives | TBO Tek Limited | Slone Indegene Limited |
|---|---|---|
| Expanding the Supplier and Buyer base | ✓ Grow network of suppliers and buyers | Not specified |
| Enhancing the value of the platform | ✓ Add new lines of businesses to the platform | Not specified |
| Pursuing inorganic growth through acquisitions | ✓ Plan strategic acquisitions for platform enhancement | Not specified |
| Utilizing data for personalized solutions | ✓ Leverage data for customized travel solutions | Not specified |
| Repayment/prepayment of indebtedness | ✗ Not specified | ✓ Repayment/prepayment of indebtedness of Material Subsidiary |
| Funding capital expenditure requirements | ✗ Not specified | ✓ Funding capital expenditure of Material Subsidiary |
| General corporate purposes and inorganic growth | ✓ General corporate purposes and inorganic growth | ✓ General corporate purposes and inorganic growth |
TBO Tek Limited Vs Indegene Limited Financial Status (Restated)
| Financial Parameters | TBO Tek Limited (₹ in Crore) | Indegene Limited (₹ in Lakhs) |
|---|---|---|
| Liabilities | 3,754.05 | 25,181.47 |
| Assets | 3,754.05 | 25,181.47 |
| Revenue | 1,039.56 | 19,697.49 |
| PAT (Profit After Tax) | 154.18 | 2,419.02 |
| Total Borrowing | 2.93 | 3,993.33 |
| Net Worth | 501.21 | 13,270.01 |
Key Performance Indicator (KPI) of TBO Tek Limited Vs Indegene Limited
| KPI | TBO Tek Limited | Indegene Limited |
|---|---|---|
| EBITDA | ₹10237.53 Lakh (18.82% margin) | ₹4198.51 Lakh (21.91% margin) |
| PAT Margin (in %) | Not specified | 12.62% |
| RoCE (Return on Capital Employed) | 44.04% | 25.02% |
| RoE (Return on Equity) | 12.22% | 18.23% |
| EPS (Earnings per Share) | ₹14.21 | ₹10.91 per share |
| PE Ratio | Not specified | Not specified |
The full detailed competition is given between the two IPOs TBO Tek Vs Indegene Limited, hope you will not have any difficulty in making a decision.
Disclaimer:
Information on IPO GMP Today is for informational purposes only. We do not provide financial advice. Investing in IPOs carries risks, including loss of principal. Consult a financial advisor before making investment decisions. Past performance doesn’t guarantee future results. The Grey Market Premium (GMP) is speculative and may not reflect actual listing prices. We’re not liable for errors or inaccuracies. Users are responsible for their own investment decisions. Use of this website implies agreement to these terms.
